CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury

被引：0
|
作者：
Lei Jiang
Dongsheng Fei
Rui Gong
Wei Yang
Wei Yu
Shangha Pan
Mingran Zhao
Mingyan Zhao
机构：
[1] The First Affiliated Hospital of Harbin Medical University,Department of ICU
[2] The First Affiliated Hospital of Harbin Medical University,The Key Hepatosplenic Surgery Laboratory, Department of General Surgery
[3] Children’s Hospital of Harbin City,Department of Pediatrics
来源：
Inflammation Research | 2016年 / 65卷
关键词：
Carbon monoxide; Acute lung injury; NLRP3 inflammasome; TXNIP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：905 / 915
页数：10
相关论文
共 50 条
  • [1] CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury
    Jiang, Lei
    Fei, Dongsheng
    Gong, Rui
    Yang, Wei
    Yu, Wei
    Pan, Shangha
    Zhao, Mingran
    Zhao, Mingyan
    INFLAMMATION RESEARCH, 2016, 65 (11) : 905 - 915
  • [2] NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury
    Kim, So Ri
    Kim, Hee Jung
    Lee, Yong Chul
    Kim, Soon Ha
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
    Yang, Jie
    Yang, Jiawen
    Huang, Xiaofang
    Xiu, Huiqing
    Bai, Songjie
    Li, Jiahui
    Cai, Zhijian
    Chen, Zhanghui
    Zhang, Shufang
    Zhang, Gensheng
    MEDIATORS OF INFLAMMATION, 2022, 2022
  • [4] Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation
    Jiang, Lei
    Zhang, Lei
    Kang, Kai
    Fei, Dongsheng
    Gong, Rui
    Cao, Yanhui
    Pan, Shangha
    Zhao, Mingran
    Zhao, Mingyan
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 130 - 138
  • [5] Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
    Shan, Mengtian
    Wan, Huimin
    Ran, Linyu
    Ye, Jihui
    Xie, Wang
    Lu, Jingjing
    Hu, Xueping
    Deng, Shengjie
    Zhang, Wenyu
    Chen, Miao
    Wang, Feilong
    Guo, Zhongliang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1369 - 1384
  • [6] Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver
    Seo, Hye-Young
    Lee, So-Hee
    Park, Ji Yeon
    Han, Eugene
    Han, Sol
    Hwang, Jae Seok
    Kim, Mi Kyung
    Jang, Byoung Kuk
    PLOS ONE, 2023, 18 (08):
  • [7] Luteolin ameliorates LPS-induced acute liver injury by inhibiting TXNIP-NLRP3 inflammasome in mice
    Wang, Xiaohui
    Wang, Lu
    Dong, Renchao
    Huang, Kai
    Wang, Changyuan
    Gu, Jiangning
    Luo, Haifeng
    Liu, Kexin
    Wu, Jingjing
    Sun, Huijun
    Meng, Qiang
    PHYTOMEDICINE, 2021, 87
  • [8] The ROS/TXNIP/NLRP3 pathway mediates LPS-induced microglial inflammatory response
    Zhao, Qianlei
    Liu, Guanhao
    Ding, Qiang
    Zheng, Feixia
    Shi, Xulai
    Lin, Zhongdong
    Liang, Yafeng
    CYTOKINE, 2024, 181
  • [9] Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury
    Wei, Shanshan
    Xiao, Zijun
    Huang, Jie
    Peng, Zhenyu
    Zhang, Bikui
    Li, Wenqun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 105
  • [10] Inhibition of GGPPS1 attenuated LPS-induced acute lung injury and was associated with NLRP3 inflammasome suppression
    Xu, Wu-jian
    Wang, Xiao-xia
    Jin, Jia-jia
    Zou, Qian
    Wu, Lin
    Lv, Tang-feng
    Wan, Bing
    Zhan, Ping
    Zhu, Su-hua
    Liu, Hong-bing
    Zhao, Ning-wei
    Li, Chao-jun
    Song, Yong
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2019, 316 (03) : L567 - L577
12345